Quince Therapeutics, Inc. (QNCX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.63M | -10.48M | -9.93M | -11.41M | -9.6M | -7.55M | -7.26M | -8.74M | -8.35M | -6.08M | -4.82M | -3.83M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 20.56% | -38.78% | -36.75% | -30.62% | -14.94% | -24.25% | -50.68% | -128.35% | -134.04% | -4.16% | 28.06% | 75.17% |
| Net Income | 35.91M | -39.46M | -13.44M | -16.05M | -15.03M | -12.46M | -5.49M | -27.73M | -11.15M | -8.89M | -5.35M | -4.89M |
| Depreciation & Amortization | 36K | 39K | 36K | 35K | 32K | 16K | 86K | 44K | 40K | 304K | 0 | 1K |
| Stock-Based Compensation | 1.29M | 1.19M | 1.25M | 1.27M | 1.39M | 1.13M | 1.12M | 1.22M | 1.27M | 1.09M | 1.33M | 1.32M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.82M | 0 | 0 |
| Other Non-Cash Items | -30.41M | 15.28M | 2.03M | 5.2M | 1.96M | 1.87M | -2.83M | 19.14M | 2.29M | 3M | -719K | -465K |
| Working Capital Changes | -14.45M | 12.47M | 194K | -1.87M | 2.05M | 1.9M | -152K | -1.42M | -805K | 250K | -79K | 201K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 5.91M | -1.15M | 1.63M | -1.44M | 22K | 1.35M | -825K | 342K | 59K | -127K | 55K | -1.3M |
| Cash from Investing | 12M | 8.07M | -1.78M | 6.04M | 10.9M | 10.87M | 7.11M | -4.98M | 8.91M | 5.39M | 3.63M | -20.32M |
| Capital Expenditures | 0 | -4K | -74K | -126K | -148K | -133K | -46K | -39K | -39K | -24K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.12M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 355K | 490K | 0 | 0 | 0 | -500K | -500K | 0 |
| Cash from Financing | 9.44M | 2.03M | 1.38M | 14.41M | 87K | 0 | -5M | 35K | 190K | 57K | 10K | 26K |
| Debt Issued (Net) | -5.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6K | 0 | 0 |
| Equity Issued (Net) | 14.99M | 2.03M | 1.38M | 0 | 87K | 0 | 0 | 35K | 190K | 57K | 10K | 26K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 14.41M | 0 | 0 | -5M | 0 | 0 | 6K | 0 | 0 |
| Net Change in Cash | 12.35M | -643K | -10.37M | 9.05M | 1.56M | 3.54M | -5.21M | -13.92M | 1.06M | -880K | -1.02M | -24.06M |
| Free Cash Flow | -7.63M | -10.48M | -10M | -11.54M | -9.75M | -7.68M | -7.31M | -8.78M | -8.39M | -6.1M | -4.82M | -3.83M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 21.77% | -36.43% | -36.9% | -31.48% | -16.17% | -25.94% | -51.64% | -129.37% | -126.5% | -3.2% | 28.59% | 75.17% |
| FCF per Share | -1.52 | -2.09 | -1.85 | -2.47 | -2.22 | -1.78 | -1.69 | -2.04 | -1.95 | -1.49 | -1.34 | -1.07 |
| FCF Conversion (FCF/Net Income) | -0.21x | 0.27x | 0.74x | 0.71x | 0.64x | 0.61x | 1.32x | 0.32x | 0.75x | 0.68x | 0.90x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 64K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |